These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30067725)

  • 41. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
    Wang J; Tian Y; Chen H; Li H; Zheng S
    Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of candidate genes for necrotizing enterocolitis based on microarray data.
    Chen G; Li Y; Su Y; Zhou L; Zhang H; Shen Q; Du C; Li H; Wen Z; Xia Y; Tang W
    Gene; 2018 Jun; 661():152-159. PubMed ID: 29605607
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.
    Schlumberger W; Hornig N; Lange S; Probst C; Komorowski L; Fechner K; Dähnrich C; Stöcker W
    Autoimmun Rev; 2014 Feb; 13(2):108-13. PubMed ID: 24075959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery.
    Ngai HH; Sit WH; Jiang PP; Xu RJ; Wan JM; Thongboonkerd V
    J Proteome Res; 2006 Nov; 5(11):3038-47. PubMed ID: 17081055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrative analysis of human protein, function and disease networks.
    Liu W; Wu A; Pellegrini M; Wang X
    Sci Rep; 2015 Sep; 5():14344. PubMed ID: 26399914
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein-Protein Interaction Network Analysis of Salivary Proteomic Data in Oral Cancer Cases.
    Amiri Dash Atan N; Koushki M; Rezaei Tavirani M; Ahmadi NA
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1639-1645. PubMed ID: 29937423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of an immunorelated protein-protein interaction network for clarifying the mechanism of burn.
    Gao Y; Nai W; Yang L; Lu Z; Shi P; Jin H; Wen H; Wang G
    Burns; 2016 Mar; 42(2):405-13. PubMed ID: 26739088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional Analysis of OMICs Data and Small Molecule Compounds in an Integrated "Knowledge-Based" Platform.
    Dubovenko A; Nikolsky Y; Rakhmatulin E; Nikolskaya T
    Methods Mol Biol; 2017; 1613():101-124. PubMed ID: 28849560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Network Tools for the Analysis of Proteomic Data.
    Chisanga D; Keerthikumar S; Mathivanan S; Chilamkurti N
    Methods Mol Biol; 2017; 1549():177-197. PubMed ID: 27975292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graphical identification of cancer-associated gene subnetworks based on small proteomics data sets.
    Mezhoud K
    OMICS; 2013 Jul; 17(7):393-7. PubMed ID: 23642253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein-protein interaction networks and different clustering analysis in Burkitt's lymphoma.
    Liu C; Liu L; Zhou C; Zhuang J; Wang L; Sun Y; Sun C
    Hematology; 2018 Aug; 23(7):391-398. PubMed ID: 29189103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis.
    Li L; Liu H; Hu X; Huang Y; Wang Y; He Y; Lei Q
    Mol Med Rep; 2018 Jun; 17(6):7708-7720. PubMed ID: 29620197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioinformatic approach to identify chaperone pathway relationship from large-scale interaction networks.
    Gong Y; Zhang Z; Houry WA
    Methods Mol Biol; 2011; 787():189-203. PubMed ID: 21898237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.
    Gao H; Wang H; Yang W
    Int J Hematol; 2017 Jul; 106(1):99-107. PubMed ID: 28316065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of systems biology to decipher host-pathogen interaction networks and predict biomarkers.
    Dix A; Vlaic S; Guthke R; Linde J
    Clin Microbiol Infect; 2016 Jul; 22(7):600-6. PubMed ID: 27113568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of Chronic Kidney Disease.
    Zhou LT; Qiu S; Lv LL; Li ZL; Liu H; Tang RN; Ma KL; Liu BC
    Kidney Blood Press Res; 2018; 43(2):568-581. PubMed ID: 29642064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Network-Assisted Disease Classification and Biomarker Discovery.
    Strunz S; Wolkenhauer O; de la Fuente A
    Methods Mol Biol; 2016; 1386():353-74. PubMed ID: 26677191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.